Therapeutic Asset Ratings

146 results matching 1 filter

128,359 assets · 8,667 sponsors · 3,127 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
TACROLIMUS inborn error of immunity	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
TACROLIMUS metastatic malignant neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
TACROLIMUS telomere syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
TACROLIMUS dyskeratosis congenita and related telomere biology disorder	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (53)
DARATUMUMAB Hodgkins lymphoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (53)
Eflornithine prostate cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (52)
Polyiclc Colorectal Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (52)
Polyiclc Cancer of the Pancreas	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1	CCC (52)
Dcsz11 rectal carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (51)
Itacitinib myeloproliferative neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (51)
LISTERIA MONOCYTOGENESSTRAIN STRAIN CRS-207 pancreatic neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (51)
METRONIDAZOLE metastatic prostate carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (51)
Botensilimab pancreatic neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (50)
Itacitinib chronic myelomonocytic leukemia	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (50)
Enoblituzumab prostate cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (49)
Retifanlimab metastatic malignant neoplasm in the colon	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (49)
Senaparib fallopian tube cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (48)
Tadalafil pancreatic neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (48)
Darolutamide cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (48)
Durvalumab fibrolamellar hepatocellular carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (48)
lutetium (<sup>177</sup>Lu) zadavotide guraxetan nonpapillary renal cell carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (48)
Nivolumab childhood neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (48)
Itacitinib myelodysplastic syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CC (47)
Belzutifan Prostate Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CC (46)
BMS 986253 pancreatic neoplasm	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CC (46)

Showing 76 to 100 of 146 assets

PreviousPage 4 of 6Next